Skip to content
TurboJournal

Zimbabwe Declines ‘One-Sided’ US Healthcare Assistance Agreement Because of Information Concerns

Health funding illustration
The offered US financial assistance was aimed at programmes for treating and preventing HIV/Aids, tuberculosis, and malaria.

Zimbabwe has rejected a major American healthcare agreement valued at 367 million US dollars (272 million pounds) over five years due to Washington's request for sensitive biological samples.

The decision was revealed after a internal memorandum dated December was leaked, indicating that President Emmerson Mnangagwa felt the arrangement was "unbalanced".

A government spokesman later stated that the US was seeking genetic material for scientific study and commercial gain while was unwilling to share the resulting advantages from future treatments.

"We must now begin the difficult and regrettable process of winding down our health assistance in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.

Her embassy said the US had furnished over $1.9bn as health assistance to Zimbabwe during the past twenty years.

A medical body in Zimbabwe has called for further negotiations to reach a agreement agreeable to all parties so the nation's vital HIV programme can continue.

Broader Background

Zimbabwe's decision comes after a similar situation in neighbouring Kenya, where a court halted a related health funding agreement following concerns were filed about the safety of citizens' medical information.

Since returning to the presidency last year, US President Donald Trump has reduced foreign aid and closed the US Agency for International Development (USAID).

USAID had managed assistance for the US government, but Trump stated its expenditure was "inefficient" and his administration was pursuing direct bilateral deals to boost transparency and responsibility.

As per reports, 16 nations in Africa have so far agreed to these new health pacts, representing over $18.3bn of fresh investment.

Details of the Declined Deal

This assistance for Zimbabwe would have funded "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".

"We are confident this collaboration might have yielded extraordinary benefits for Zimbabwean communities, especially the 1.2 million currently receiving HIV treatment via US-supported initiatives," the Ambassador said.

However, official spokesman Nick Mangwana argued the arrangement was "unequal".

"The proposal required Zimbabwe to share its genetic material and health information over an extended period, with no equivalent assurance of access to any medical innovations – like new medicines or tests – that might result from that provided information," his statement read.

"Put simply, our country would provide the basic resources for scientific discovery without any assurance that the resulting innovations would be available to our population if a future pandemic arise."

Sovereignty and Global Health

Mangwana further said that the American exit from the World Health Organization (WHO) and its push of bilateral health agreements were disrupting structures already set up through the international organization.

Mangwana gave as an example its Pandemic Benefit-Sharing scheme created to deal with potential global health emergencies.

"This framework is designed to guarantee that when a nation provides its samples, the resulting advantages – such as vaccines and treatments – are shared equitably, not monopolised solely by those with the funds to develop them."

Zimbabwe's reservations regarding the US deal "should not be misconstrued as anti-American sentiment," he added.

"We welcome further dialogue with our US partners on how subsequent co-operation could be designed in a manner that honours the sovereignty and dignity of each country."

Medical Community Response

A leading public health body said it recognised the official position, but recommended that talks should continue since a large portion of the nation's Aids initiatives depended on international support.

"If technical issues exist, such as those involving information security or implementation frameworks, these can frequently be addressed through detailed discussion and mutually agreed protections," the group commented.

The halted deal highlights the complex challenges between receiving crucial international aid and safeguarding local interests in an ever more data-driven world.

The writer

Melinda Sawyer

A tech journalist with a passion for exploring emerging technologies and their impact on everyday life.

TurboJournal

Type to search articles.